88353-04-2 Usage
General Description
Dodecanedioic acid, mono(phenylmethyl) ester is a chemical compound that is used in the production of various industrial materials, including polymers, resins, and adhesives. It is a white solid with a faint odor and is insoluble in water but soluble in organic solvents. Dodecanedioic acid, mono(phenylmethyl) ester is known for its ability to improve the flexibility and durability of materials, making it a valuable ingredient in the manufacturing of products such as coatings, sealants, and plasticizers. Dodecanedioic acid, mono(phenylmethyl) ester also has potential applications in the pharmaceutical and personal care industries due to its properties as a lubricant and emollient. However, it is important to handle this chemical with caution and adhere to proper safety measures, as it may pose health and environmental risks if not used and disposed of properly.
Check Digit Verification of cas no
The CAS Registry Mumber 88353-04-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,3,5 and 3 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 88353-04:
(7*8)+(6*8)+(5*3)+(4*5)+(3*3)+(2*0)+(1*4)=152
152 % 10 = 2
So 88353-04-2 is a valid CAS Registry Number.
88353-04-2Relevant articles and documents
HDAC DEGRADER
-
Page/Page column 37-38; 46, (2021/07/31)
The disclosure provides compounds of formula (I). The compounds may be used to degrade the Histone Deacetylase (HDAC) family of enzymes, particularly HDAC1, 2 and 3 that exist in corepressor complexes. Accordingly, the compounds may
THERAPEUTIC METHODS
-
Page/Page column 204; 239; 241, (2020/05/28)
The invention provides methods and compositions for delivering a nucleic acid to a cell or the cytosol of the target cell. The method includes contacting the cell with, 1) a membrane-destabilizing polymer; and 2) a nucleic acid conjugate. The nucleic acid conjugate includes a targeting ligand bound to an optional linker and a nucleic acid.
TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS
-
Page/Page column 82; 100; 101, (2018/11/10)
The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.
